Menlo Therapeutics Inc. Business Operations Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sales Agreement, dated as of
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2024
Controlled Equity Offering Sales AgreementSM, dated August 12, 2021, by and between VYNE Therapeutics Inc. and Cantor Fitzgerald & Co
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
Termination of Employment Agreement and Release, dated as of March 22, 2020, by and between Foamix Pharmaceuticals Ltd. and Ilan Hadar
Termination Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Form of Foamix Voting Agreement, dated November 10, 2019, by and between Menlo Therapeutics Inc. and certain shareholders of Foamix Pharmaceuticals Ltd
Voting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Form of Menlo Voting Agreement, dated November 10, 2019, by and between Foamix Pharmaceuticals Ltd. and certain stockholders of Menlo Therapeutics Inc
Voting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Professional Services Agreement, dated June 1, 2019, by and between the Company and Mary Spellman, M.D
Services Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2019
License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc
Collaboration Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
Form of Indemnification Agreement for directors and executive officers to be entered into following the offering
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Form of Indemnification Agreement entered into between the Company and each of its directors and executive officers
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc
Collaboration Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017